Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Clinical trial NCT03562377 · COMPLETED
Trial details
- NCT number
- NCT03562377
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-13
- Primary completion
- 2019-09-17
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.